Jonathan Strosberg
MD
Associate Professor of Medicine
👥Biography 个人简介
Jonathan Strosberg led the landmark NETTER-1 trial that established Lu-177-DOTATATE (Lutathera) as standard of care for midgut neuroendocrine tumors at Moffitt Cancer Center. His work has transformed the PRRT landscape and informed dosimetry, patient selection, and combination strategies with PRRT. He continues to lead investigations of next-generation radiopeptide therapies and predictive biomarkers for PRRT response. He is one of the world's most cited NET researchers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jonathan Strosberg 的研究动态
Follow Jonathan Strosberg's research updates
留下邮箱，当我们发布与 Jonathan Strosberg（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment